October 2020 | Volume 1
This edition’s articles survey the challenges that continue to plague our healthcare system and the wellness of our nation (even aside from COVID-19), including out-of-balance costs (and not just the drugs, folks), a predisposition to invest heavily in new, shiny technology without understanding its optimal use and lacking structures to guide its application, suboptimal use and sharing of vital data, and grossly under-funded public health and safety-net health systems. The next month will reveal whether we have even more to overcome, or the potential to build, strengthen and recommit to a healthy society.
The Case for Algorithmic Stewardship for Artificial Intelligence and Machine Learning Technologies
The first manual on hospital administration, published in 1808, described a hospital steward as “an individual who [is] honest and above reproach,” with duties including the purchasing and management of hospital materials. Today, a steward’s job can be seen as ensuring the safe and effective use of clinical resources.
Americans Want Federal Government to Make Sharing Electronic Health Data Easier
A survey released Sept. 16 shows that clear majorities of Americans support efforts to improve how their medical information is shared among doctors and clinicians, and that they want greater access to their own health data.
Drugs aren't the reason the U.S. spends so much on health care
Voters care a lot about drug prices, but they’re not the main reason the U.S. spends so much on health care.
The big picture: The U.S. spends twice as much per person as other wealthy nations, according to a new Peterson-Kaiser Tracker analysis — and hospitals and outpatient care are the primary culprits.
Improving Pandemic Preparedness: Lessons From COVID-19
The United States and the world were caught unprepared by the COVID-19 pandemic despite decades of warnings of the threat of global pandemics and years of international planning. The failure to adequately fund and execute these plans has exacted a heavy human and economic price.
Confronting State Medicaid Drug Spending Pressures
Across the country, state Medicaid budgets are under increasing strain, driven by factors including the high and increasing prices of prescription drugs. Nearly 30% of state spending supports Medicaid programs, and Medicaid programs spent more than $29 billion on prescription drugs in 2017 after accounting for manufacturer discounts.
De-adopting Low-Value Care: Evidence, Eminence, and Economics
An often cited shortcoming of the US health care system is the slow pace with which new innovations are adopted into routine clinical practice. A parallel problem receives comparably less attention: the US and other countries are slow to abandon practices that provide little or no benefit to patients.

Passion + Quality = Change That Matters
I embrace the powerful opportunities in our evolving health care landscape. I founded Momentum Health Strategies to be a catalyst for change through continuous learning, diverse engagement and thoughtful policy and practice initiatives. I deliver innovative, strategic thinking and a passion for improving the patient experience. My personal drive and dedication to high-quality results will help you navigate the competitive terrain you face and convert your vision to action.

Momentum Health Strategies

Jennifer L Bright, MPA
(703) 628 - 0534